COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 89 of 559 for:    ESCITALOPRAM AND Disorders

Pioglitazone as an Adjunct for Moderate to Severe Depressive Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01109030
Recruitment Status : Completed
First Posted : April 22, 2010
Last Update Posted : May 9, 2012
Information provided by (Responsible Party):
Amirhossein Modabbernia, Tehran University of Medical Sciences

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2011
Actual Study Completion Date : October 2011